【正文】 nemann, et al .pHsensitive nanoparticles of poly(amino acid) dodecanoate plexes. International Journal of Pharmaceutics, 2022, 230: 11~24 26 Ito Y, Casolaro M, Kono K， et al. An insulinreleasing system that is responsive to glucose. Journal of Controlled Release, 1989, 10: 195~203 27 Kost J, Noecker R, Kunica E, et al. Magically controlledrelease systems: effect of polymer position. J. Biomed. Mater. Res., 1986, 19: 935 28 Okahata Y, Noguchi H, Seki T, et al. Thermoselective permeation from a polymergrafted capsules membrane. Macroposiummolecules, 1986, 19: 493~494 29 Miyazaki S, Yokouchi C, Takada M. External control of drug release: controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats. J. Pharm. Pharmacol., 1988, 40: 716~717 30 Domb A J. Lipospheres for controlled delivery of substances. United States Patent, 1993, USS 188837 267 31 Muller R H, Lucks J S. Arzneistofftrager aus festen Lipidteilchen, Feste Lipidnanospharen (SLN). European Patent, 1996, 0605497 32 Muller R H, Schwarz C, Mehnert W. Production of solid lipid nanoparticles (SLN) for controlled drug delivery. Proc. Int. Symp. Control Release Bioact. Mater., 1993, 20: 480~481 33 Gasco M R. Method for producing solid lipid microspheres having a narrow size distribution. US Patent, 1993, 5 250 236 34 陳大兵，楊天智，呂萬良，等．紫杉醇長循環(huán)固態(tài)脂質(zhì)納米粒的制備和體內(nèi)外研究．藥學(xué)學(xué)報(bào)，2022， 37（ 1）： 54~58 35 王 黎，侯新樸．靶敏感脂質(zhì)體的研究進(jìn)展．中國新藥雜志， 2022， 9（ 8）： 516~518 36 Peracchia M T, Fattal E, Desmaele D, et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. Journal of Controlled Release, 1999, 60: 121~128 37 張中冕，段芳齡，張明智，等．脂質(zhì)體豬苓多糖抗肝轉(zhuǎn)移癌作用的研究．胃腸病學(xué)和肝病學(xué)雜志， 1999， 8（ 3）： 180~182 38 丁玉玲，馬淑賢，盧秀榮，等．人參皂甙脂質(zhì)體 (GSL)的研制．中國藥學(xué)雜志， 1995， 30（ 7）：414~417 39 Ishida T, Kirchmeier M J, Moase E H, et al. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta, 2022, 1515(2): 144~158 40 Hong M S, Lim S J, Oh Y K, et al. pHsensitive, serumstable and longcirculating liposomes as a new drug delivery system. J. Pharm. Pharmacol., 2022, 54(1): 51~58 41 Kono K, Yoshino K, Takagishi T. Effect of poly(ethylene glycol) grafts on temperaturesensitivity of thermosensitive polymermodified liposomes. Journal of Controlled Release, 2022, 80(13): 321~332 42 Koning G A， Morselt H W， Velinova M J， et al. Selective transfer of a lipophilic prodrug of 5fluorodeoxyuridine from immunoliposomes to colon cancer cells. Biochim Biophys Acta, 1999, 1420:153~167 43 Chang J S, Choi M J, Kim T Y, et al .Immunogenicity of synthetic HIV1 V3 loop peptides by MPL adjuvanted pHsensitive liposomes. Vaccine, 1999 ,17(1112):1540~1548 44 Brime B, Moreno M A, Frutos G, et al. Amphotericin B in oilwater lecithinbased microemulsions: Formulation and toxicity evaluation. J. Pharm. Sci., 2022, 91(4): 1178~1185 45 吳永良，盧海燕． O/W 型中藥按摩微乳的制備研究．海峽藥學(xué)， 2022， 12（ 1）： 20~21 268 46 鄒麗娟，李 杰．β 欖香烯抗癌作用與誘發(fā)腫瘤細(xì)胞凋亡的研究．大連醫(yī)科大學(xué)學(xué)報(bào)， 1998，20（ 2）： 9~12 47 李大鵬．康萊特注射液抗癌作用機(jī)理研究進(jìn)展．中藥新藥與臨床藥理， 2022， 12（ 2）： 122~124 48 Kushida I, Ichikawa M, Asakawa N. Improvement of dissolution and oral absorption of ER34122, a poorly watersoluble dual 5lipoxygenase/cyclooxygenase inhibitor with antiinflammatory activity by preparing solid dispersion. J. Pharm. Sci., 2022, 91(1): 258~266 49 肖玉秀，耿 灝，張 凱．阿司匹林固體分散物的研究．中國現(xiàn)代應(yīng)用藥學(xué)雜志， 1999， 16（ 5）：20~22 50 吳 偉，周 全，張恒弼，等．尼莫地平固體分散體的制備及體外研究．中國藥學(xué)雜志 ， 1998，33（ 1）： 29~32 51 Moneghini M, Kikic I, Voinovich D, et al. Processing of carbamazepine–PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution. International Journal of Pharmaceutics, 2022, 222 : 129~138 52 鄧 莉，鄒 豪，蔣雪濤．水飛薊賓固體分散體的制備及體外溶出研究．第二軍醫(yī)大學(xué)學(xué)報(bào)，2022， 21（ 10）： 961~964 53 F Veiga, C Fernandes, F Teixeira. Oral bioavailability and hypoglycaemic activity of tolbutamide: cyclodextrin inclusion plexes. International Journal of Pharmaceutics, 2022, 202: 165~171 54 Ikeda Yoichi, Kimura Kenya, Hirayama Fumitoshi, et al. Controlled release of a watersoluble drug, captopril, by a bination of hydrophilic and hydrophobic cyclodextrin derivatives. Journal of Controlled Release, 2022, 66(3): 271~280 55 顏耀東，馮 波，黃曉潔，等．齊墩果酸 β 環(huán)糊精包合物的研究．中成藥， 1995， 17（ 6）： 4 56 楊紅武，毛衍平，邱應(yīng)海，等．纈草β 環(huán)糊精包合物的工藝及穩(wěn)定性研究．中國醫(yī)院藥學(xué)雜志，1998， 18（ 12）： 544 57 McCormack B, Gregoriadis G. Entrapment of cyclodextrindrug plexes into liposomes: potential advantages in drug delivery. J. Drug Target, 1994, 2(5): 449~454 58 McCormack B, Gregoriadis G. Drugsinliposomes: An approach to controlling the fate of water insoluble drugs in vivo. Int. J. Pharm., 162 : 59~69 （ 楊祥良、劉宏 ）